Results 141 to 150 of about 23,635 (197)

Urokinase-Type Plasminogen Activator Receptor (uPAR) Expression and [⁶⁴Cu]Cu-DOTA-AE105 uPAR-PET/CT in Patient-Derived Xenograft Models of Oral Squamous Cell Carcinoma. [PDF]

Mol Imaging Biol, 2023
Lawaetz M, Binderup T, Christensen A, Juhl K, Lelkaitis G, Lykke E, Knudsen L, von Buchwald C, Kjaer A.   +8 more
europepmc   +1 more source

Interactive Effects of IL-1β and TGF-β on Urokinase-Type Plasminogen Activator and α-Smooth Muscle Actin Expression by Corneal Fibroblasts. [PDF]

Invest Ophthalmol Vis Sci
Sugioka K, Nishida T, Yunoki M, Mukai N, Murakami J, Kusaka S.   +5 more
europepmc   +1 more source

Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) and Growth Differentiation Factor-15 (GDF-15) Levels Are Significantly Associated with Endothelial Injury Indices in Adult Allogeneic Hematopoietic Cell Transplantation Recipients. [PDF]

Int J Mol Sci, 2023
Gavriilaki E, Bousiou Z, Batsis I, Vardi A, Mallouri D, Koravou EE, Konstantinidou G, Spyridis N, Karavalakis G, Noli F, Patriarcheas V, Masmanidou M, Touloumenidou T, Papalexandri A, Poziopoulos C, Yannaki E, Sakellari I, Politou M, Papassotiriou I.   +18 more
europepmc   +1 more source

Remodeling the sarcoma microenvironment by simultaneous targeting of urokinase-type plasminogen activator receptors and epidermal growth factor receptors to promote antitumor activity. [PDF]

J Pharmacol Exp Ther
Schulte AJ, Lewellen M, Durose W, Nolan E, Taghizadeh L, Todhunter D, Bush C, Lang HP, Brown ME, DePauw TA, Makielski KM, Kim JH, Burt LE, Overn P, Forster CL, Seelig DM, O'Sullivan MG, Weigel BJ, Murugan P, Cutter GR, Lund TC, Vallera DA, Modiano JF.   +22 more
europepmc   +1 more source

Author Correction: Urokinase-type plasminogen activator receptor (uPAR) assessed by liquid biopsies and PET/CT for prognostication in head and neck cancer patients. [PDF]

Sci Rep, 2023
Risør LM, Binderup T, Fosbøl MØ, Andersen KF, Loft A, Friborg J, Kjaer A.   +6 more
europepmc   +1 more source

Urokinase-type plasminogen activator deficiency enhances CD8⁺ T cell infiltration and anti-PD-1 therapy efficacy in prostate cancer. [PDF]

Front Immunol
Li X, Zhang X, Fu X, Wu H, Ye X, Huang X, Cui Y, Qian CN, Lu Y, Zhang J.   +9 more
europepmc   +1 more source

A Novel Marine Pyran-Isoindolone Compound Enhances Fibrin Lysis Mediated by Single-Chain Urokinase-Type Plasminogen Activator. [PDF]

Mar Drugs, 2022
Gao C, Tang S, Zhang H, Zhang H, Zhang T, Bao B, Zhu Y, Wu W.   +7 more
europepmc   +1 more source

Serum Soluble Urokinase-Type Plasminogen Activator Receptor: A Promising Biomarker for Stable Chronic Obstructive Pulmonary Disease Patients. [PDF]

Cureus
D R, Johnson P, Das S, Gr S.
europepmc   +1 more source

Urokinase-Type Plasminogen Activator Enhances the Neuroprotective Activity of Brain-Derived Neurotrophic Factor in a Model of Intracerebral Hemorrhage. [PDF]

Biomedicines, 2022
Dzhauari S, Litvinova S, Efimenko A, Aleksandrushkina N, Basalova N, Abakumov M, Danilova N, Malkov P, Balabanyan V, Bezuglova T, Balayants V, Mnikhovich M, Gulyaev M, Skryabina M, Popov V, Stambolsky D, Voronina T, Tkachuk V, Karagyaur M.   +18 more
europepmc   +1 more source

Urokinase-type plasminogen activator receptor (uPAR) assessed by liquid biopsies and PET/CT for prognostication in head and neck cancer patients. [PDF]

Sci Rep, 2022
Risør LM, Binderup T, Fosbøl MØ, Andersen KF, Loft A, Friborg J, Friborg J, Kjaer A.   +7 more
europepmc   +1 more source